Showing results (301-310 of 1,225) with videos related to

Sort By:
Pageof 123
Molecular Cell|October 7, 2003
Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130Martin J Boulanger, Alexander J Bankovich, Tanja Kortemme, et al.
The Journal of Emergency Medicine|July 29, 2008
Unintentional ingestion of bupropion in childrenHenry A Spiller, George M Bosse, Michael Beuhler, et al.
The Journal of Biological Chemistry|November 21, 2008
Rationally designed integrin beta3 mutants stabilized in the high affinity conformationBing-Hao Luo, John Karanicolas, Laura D Harmacek, et al.
AIDS (London, England)|January 3, 2020
Switch from tenofovir disoproxil fumarate to raltegravir is not associated with weight gain over 96 weeksMirella Carr, Robyn Richardson, Winnie Tong, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2013
The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysisEleanor James, Ruth Dobson, Jens Kuhle, et al.
Journal of the American Pharmacists Association : Japha|August 31, 2019
Evaluation of a pharmacist-led naloxone coprescribing program in primary careDesmond Cariveau, Allison E Fay, David Baker, et al.
Journal of Neurosurgery. Case Lessons|March 3, 2025
Robot-assisted MRI-guided laser interstitial thermal therapy for a giant sessile hypothalamic hamartoma in an 8-year-old boy: illustrative caseMolly Butler, Christopher Carr, David Baker, et al.
Structure (London, England : 1993)|April 8, 2003
Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligandsBenjamin J McFarland, Tanja Kortemme, Shuyuarn F Yu, et al.
Annals of Clinical and Translational Neurology|August 13, 2019
Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis modelDavid Baker, Erik Nutma, Helen O'Shea, et al.
Multiple Sclerosis and Related Disorders|December 13, 2021
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosisDavid Baker, Amy MacDougall, Angray S Kang, et al.
Pageof 123